The purpose of this study is to determine if intrapartum use of a glucose-containing solution will improve the outcomes in pregnant women and their babies.
This will be a multi-center, prospective, single-blind randomized trial of two types of IV fluids for maintenance hydration during labor. This study will be conducted at 4 sites: Reading (Reading Hospital), Allentown (Lehigh Valley), St. Luke Hospital and Hershey (Penn State College of Medicine). It will include 1524 pregnant women at ≥ 36 weeks presenting in spontaneous labor for anticipated delivery. The primary research hypothesis is that intravenous hydration during labor with a glucose-containing fluid will lead to more efficient uterine contractility and will lead to a reduction of cesarean delivery. The primary outcome measure is the occurrence of a cesarean birth during the study period. The primary analysis will use an intent-to-treat approach to examine differences between the two IV fluid treatments in the proportion of deliveries requiring cesarean section.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
318
D5LR IV fluid
LR IV fluid
Lehigh Valley Hospital
Allentown, Pennsylvania, United States
St. Luke Hospital
Bethlehem, Pennsylvania, United States
The Penn State University
Hershey, Pennsylvania, United States
The Reading Hospital and Medical Center
Reading, Pennsylvania, United States
C-Section
Compare c-section rates between the D5LR and LR treatment groups
Time frame: From onset of labor to delivery
Oxytocin Augmentation
Compare augmentation rates between the D5LR and LR treatment groups
Time frame: From onset of labor to delivery
Time to Delivery
Compare time to delivery between the D5LR and LR treatment groups
Time frame: From onset of labor to delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.